Literature DB >> 26298389

Molecular imaging and neural networks in impulse control disorders in Parkinson's disease.

I Aracil-Bolaños1, A P Strafella2.   

Abstract

Impulse control disorders (ICDs) may arise in Parkinson's disease (PD) in relation to the use of dopamine agonists (DA). A dysfunction of reward circuits is considered the main underlying mechanism. Neuroimaging has been largely used in this setting to understand the structure of the reward system and its abnormalities brought by exogenous stimulation in PD. Dopaminergic changes, such as increased dopamine release, reduced dopamine transporter activity and other changes, have been shown to be a consistent feature of ICDs in PD. Beyond the striatum, alterations of prefrontal cortical function may also impact an individuals' propensity for impulsivity. Neuroimaging is advancing our knowledge of the mechanisms involved in the development of these behavioral addictions. An increased understanding of these disorders may lead to the discovery of new therapeutic targets, or the identification of risk factors for the development of these disorders.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Impulse control disorders; Molecular imaging; Parkinson's disease

Mesh:

Substances:

Year:  2015        PMID: 26298389      PMCID: PMC4874782          DOI: 10.1016/j.parkreldis.2015.08.003

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  34 in total

1.  Orbitofrontal connectivity with resting-state networks is associated with midbrain dopamine D3 receptor availability.

Authors:  David M Cole; Christian F Beckmann; Graham E Searle; Christophe Plisson; Andri C Tziortzi; Thomas E Nichols; Roger N Gunn; Paul M Matthews; Eugenii A Rabiner; John D Beaver
Journal:  Cereb Cortex       Date:  2011-12-19       Impact factor: 5.357

2.  Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole.

Authors:  Matthias R Lemke; H Michael Brecht; Juergen Koester; Peter H Kraus; Heinz Reichmann
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

3.  Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas.

Authors:  Jana Martinkova; Ludmila Trejbalova; Michaela Sasikova; Jan Benetin; Peter Valkovic
Journal:  Clin Neuropharmacol       Date:  2011 Sep-Oct       Impact factor: 1.592

Review 4.  Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity.

Authors:  Robert F Leeman; Marc N Potenza
Journal:  Psychopharmacology (Berl)       Date:  2011-11-05       Impact factor: 4.530

5.  Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate.

Authors:  Maude Beaudoin-Gobert; Justine Epinat; Elise Météreau; Sandra Duperrier; Sara Neumane; Bénédicte Ballanger; Franck Lavenne; François Liger; Christian Tourvielle; Frédéric Bonnefoi; Nicolas Costes; Didier Le Bars; Emmanuel Broussolle; Stéphane Thobois; Léon Tremblay; Véronique Sgambato-Faure
Journal:  Brain       Date:  2015-06-27       Impact factor: 13.501

6.  Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study.

Authors:  Nicola J Ray; Janis M Miyasaki; Mateusz Zurowski; Ji Hyun Ko; Sang Soo Cho; Giovanna Pellecchia; Francesca Antonelli; Sylvain Houle; Anthony E Lang; Antonio P Strafella
Journal:  Neurobiol Dis       Date:  2012-07-03       Impact factor: 5.996

Review 7.  Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.

Authors:  Valerie Voon; Pierre-Olivier Fernagut; Jeff Wickens; Christelle Baunez; Manuel Rodriguez; Nancy Pavon; Jorge L Juncos; José A Obeso; Erwan Bezard
Journal:  Lancet Neurol       Date:  2009-12       Impact factor: 44.182

8.  Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors.

Authors:  Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; Panayotis K Thanos; Jean Logan; David Alexoff; Yu-Shin Ding; Christopher Wong; Yeming Ma; Kith Pradhan
Journal:  Neuroimage       Date:  2008-06-13       Impact factor: 6.556

9.  Dopamine-agonists and impulsivity in Parkinson's disease: impulsive choices vs. impulsive actions.

Authors:  Francesca Antonelli; Ji Hyun Ko; Janis Miyasaki; Anthony E Lang; Sylvain Houle; Franco Valzania; Nicola J Ray; Antonio P Strafella
Journal:  Hum Brain Mapp       Date:  2013-09-03       Impact factor: 5.038

10.  Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.

Authors:  Isabelle Boileau; Mark Guttman; Pablo Rusjan; John R Adams; Sylvain Houle; Junchao Tong; Oleh Hornykiewicz; Yoshiaki Furukawa; Alan A Wilson; Shitij Kapur; Stephen J Kish
Journal:  Brain       Date:  2009-01-19       Impact factor: 13.501

View more
  8 in total

Review 1.  Impulse control disorders in Parkinson's disease.

Authors:  Ana Marques; Franck Durif; Pierre-Olivier Fernagut
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

2.  Compulsive eating behaviors in Parkinson's disease.

Authors:  Ingrid de Chazeron; Franck Durif; Isabelle Chereau-Boudet; Maria Livia Fantini; Ana Marques; Philippe Derost; Berengere Debilly; Georges Brousse; Yves Boirie; Pierre Michel Llorca
Journal:  Eat Weight Disord       Date:  2019-02-04       Impact factor: 4.652

Review 3.  Psychosis in parkinsonism: an unorthodox approach.

Authors:  Marco Onofrj; Danilo Carrozzino; Aurelio D'Amico; Roberta Di Giacomo; Stefano Delli Pizzi; Astrid Thomas; Valeria Onofrj; John-Paul Taylor; Laura Bonanni
Journal:  Neuropsychiatr Dis Treat       Date:  2017-05-16       Impact factor: 2.570

4.  Parkinson's Disease: Impulsivity Does Not Cause Impulse Control Disorders but Boosts Their Severity.

Authors:  Juan Marín-Lahoz; Javier Pagonabarraga; Saul Martinez-Horta; Ramón Fernandez de Bobadilla; Berta Pascual-Sedano; Jesús Pérez-Pérez; Alexandre Gironell; Jaime Kulisevsky
Journal:  Front Psychiatry       Date:  2018-09-28       Impact factor: 4.157

5.  The Impact of Impulsivity on Quality of Life in Early Drug-Naïve Parkinson's Disease Patients.

Authors:  Dong-Woo Ryu; Joong-Seok Kim; Sang-Won Yoo; Yoon-Sang Oh; Kwang-Soo Lee
Journal:  J Mov Disord       Date:  2019-08-09

Review 6.  Impulse Control Disorders in Parkinson's Disease: Epidemiology, Pathogenesis and Therapeutic Strategies.

Authors:  Jun-Fang Zhang; Xi-Xi Wang; Ya Feng; Robert Fekete; Joseph Jankovic; Yun-Cheng Wu
Journal:  Front Psychiatry       Date:  2021-02-09       Impact factor: 4.157

Review 7.  Psychosocial Modulators of Motor Learning in Parkinson's Disease.

Authors:  Petra Zemankova; Ovidiu Lungu; Martin Bares
Journal:  Front Hum Neurosci       Date:  2016-02-29       Impact factor: 3.169

8.  Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson's Disease.

Authors:  Aleksander H Erga; Ingvild Dalen; Anastasia Ushakova; Janete Chung; Charalampos Tzoulis; Ole Bjørn Tysnes; Guido Alves; Kenn Freddy Pedersen; Jodi Maple-Grødem
Journal:  Front Neurol       Date:  2018-02-28       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.